TruDiagnostic

Ownership

Private

Therapeutic Areas

OtherImmunologyMetabolic Disorders

Stage

Commercial

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Diagnostic test (Epigenetic biomarker analysis)Device (at-home sample collection kits)Data analytics platform (epigenetic algorithms)

TruDiagnostic General Information

Contact Information

Website

https://www.trudiagnostic.com/

Primary Industry

Molecular Diagnostics

Corporate Office

Lexington, Kentucky
United States

Drug Pipeline

No pipeline data available

For full access to TruDiagnostic's pipeline data

Key Partnerships

NADMED

Need more data on over 80,000 life science companies, including over 1200 biotechs?

TruDiagnostic Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view TruDiagnostic's complete valuation and funding history, request access »

TruDiagnostic Financial Metrics